Gansu Dahe Chinese Herbal Medicine Development Co., Ltd.

Gansu Dahe Chinese Herbal Medicine Development Co., Ltd. is a Sino-foreign joint venture registered and established by the Dingxi Municipal People's Government in 2012. Registered capital: RMB 20 million, registered address: No. 3 Dinglin Road, Anding District, Dingxi City; it was listed on the Australian National Stock Exchange as "Chinese Herbal Medicine" on February 2, 2015, stock code: CHI. Became the first overseas listed company in Dingxi City. The company is a professional company with a traceable quality assurance system based on industrialization, organic seed production, seedling breeding, multiplication, planting and sales. The registered trademark is "Longzhengyuan". The company has a complete quality assurance and safety inspection system, has a seed production license, a seed business license, and a drug business license, and has passed the GSP certification. The company continues to improve the production capacity of fine seeds, innovation and transformation capabilities, and corporate competitiveness. At present, it has developed 7 high-quality varieties (species) of angelica, astragalus, and Codonopsis pilosula, and has built 3 characteristic and advantageous industrial parks mainly in Minxian County, Longxi, and Weiyuan. The total area has reached more than 1,800 mu. It is planned to increase the seed production and seedling area of three varieties in 2017 to gradually reach 15,000 mu, with an annual output of 100,000 kg of Chinese medicinal materials, 1.32 million kg of seedlings, and 400,000 kg of finished medicine. In terms of core key technologies of the Chinese herbal medicine industry, the company conducts research on new breeding materials, new breeding technologies, and excellent new varieties, and cooperates with crop-related disciplines, key laboratories, and engineering research centers in domestic colleges and universities to integrate various resources and cultivate A group of excellent varieties with key breakthroughs.

Visit Website

Manufacturer

Lu Fumin(CEO)

Long Zhengyuan

Above 10M USD

51-100 people

7

Gansu Dahe Chinese Herbal Medicine Development Co., Ltd., established through collaboration with the Dingxi Municipal People's Government, operates as a Sino-foreign joint venture since 2012. With a registered capital of RMB 20 million, the company is headquartered at No. 3 Dinglin Road, Anding District, Dingxi City. It made history by becoming the first overseas-listed company from Dingxi on the Australian National Stock Exchange under the stock code "CHI" on February 2, 2015. Specializing in the cultivation and production of Chinese medicinal herbs, Gansu Dahe emphasizes quality assurance through a traceable system covering industrialization, organic seed production, seedling breeding, and sales. The company holds licenses for seed production and drug business, along with GSP certification, ensuring adherence to rigorous quality and safety standards. Under the registered trademark "Longzhengyuan," Gansu Dahe has developed seven high-quality varieties of medicinal herbs, including angelica, astragalus, and Codonopsis pilosula. It operates three industrial parks primarily located in Minxian County, Longxi, and Weiyuan, covering a total area exceeding 1,800 mu (approximately 120 hectares). Looking ahead, the company plans substantial expansions in seed production and seedling areas to achieve annual outputs of 100,000 kg of Chinese medicinal materials, 1.32 million kg of seedlings, and 400,000 kg of finished medicine. Engaged in ongoing research and development collaborations with domestic universities and research centers, Gansu Dahe aims to innovate its breeding technologies and enhance competitiveness in the Chinese herbal medicine industry.